Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy

Clinical trial NCT01243398 · COMPLETED

Trial details

NCT number: NCT01243398
Sponsor: University of Oxford
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adenocarcinoma of the Gastroesophageal Junction Esophageal Cancer

Start date: 2009-03-01
Primary completion: 2012-05-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.